|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.9766 USD | -6.10% |
|
-30.49% | -38.19% |
| Market Cap | 18Cr 16Cr 15Cr 14Cr 26Cr 1.74TCr 26Cr 174.18Cr 68Cr 867.9Cr 69Cr 67Cr 2.91TCr | P/E 2026 * |
-2.06x | P/E 2027 * | -5.05x |
|---|---|---|---|---|---|
| Enterprise Value | 18Cr 16Cr 15Cr 14Cr 26Cr 1.74TCr 26Cr 174.18Cr 68Cr 867.9Cr 69Cr 67Cr 2.91TCr | EV / Sales 2026 * |
44.3x | EV / Sales 2027 * | 3.15x |
| Free-Float |
85.03% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Outlook Therapeutics, Inc.
| 1 day | -6.10% | ||
| 1 week | -30.49% | ||
| 1 month | -38.58% | ||
| 3 months | +290.64% | ||
| 6 months | +122.11% | ||
| Current year | -38.19% |
| 1 week | 0.82 | 1.42 | |
| 1 month | 0.82 | 1.87 | |
| Current year | 0.16 | 1.88 | |
| 1 year | 0.16 | 3.39 | |
| 3 years | 0.16 | 34 | |
| 5 years | 0.16 | 65.4 | |
| 10 years | 0.16 | 878.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Jahr
CEO | Chief Executive Officer | 54 | 01/07/2025 |
Lawrence Kenyon
CEO | Chief Executive Officer | 60 | 03/12/2024 |
Surendra Sharma
CTO | Chief Tech/Sci/R&D Officer | - | 19/01/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Lawrence Kenyon
BRD | Director/Board Member | 60 | 02/08/2018 |
Kurt Hilzinger
BRD | Director/Board Member | 65 | 11/12/2015 |
| Chairman | 41 | 31/01/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/07/26 | Buy | Chairman | 95,398 | 0.0642% | ||
| 21/07/26 | Free | Chief Executive Officer | 1,00,000 | 0.0673% | ||
| 21/07/26 | Free | Chief Financial Officer | 2,10,078 | 0.1414% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.10% | -30.49% | -50.17% | -97.18% | 19Cr | ||
| -1.40% | +2.59% | -1.71% | +11.28% | 4.94TCr | ||
| -2.41% | -0.90% | +403.17% | +614.40% | 4.09TCr | ||
| -1.16% | +12.96% | +26.45% | +5.03% | 3.91TCr | ||
| -1.88% | -3.03% | +4.94% | +47.52% | 3.58TCr | ||
| -1.74% | +5.12% | +9.58% | +46.02% | 3.05TCr | ||
| -2.85% | -3.92% | - | - | 1.66TCr | ||
| -0.21% | -4.04% | +35.09% | +127.95% | 1.61TCr | ||
| -0.64% | +2.65% | +1.25% | +8.92% | 1.37TCr | ||
| -1.19% | -1.32% | -3.32% | -34.94% | 1.28TCr | ||
| Average | -1.96% | -1.47% | +47.25% | +81.00% | 2.55TCr | |
| Weighted average by Cap. | -1.60% | +3.15% | +77.24% | +128.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 41.22L 35.83L 33.35L 30.62L 57.83L 39Cr 58.72L 3.93Cr 1.54Cr 20Cr 1.55Cr 1.51Cr 66Cr | 5.8Cr 5.04Cr 4.69Cr 4.31Cr 8.14Cr 553.64Cr 8.26Cr 55Cr 22Cr 275.62Cr 22Cr 21Cr 924.21Cr |
| Net income | -4.79Cr -4.17Cr -3.88Cr -3.56Cr -6.72Cr -457.46Cr -6.83Cr -46Cr -18Cr -227.74Cr -18Cr -18Cr -763.65Cr | -3.23Cr -2.81Cr -2.62Cr -2.4Cr -4.54Cr -308.75Cr -4.61Cr -31Cr -12Cr -153.71Cr -12Cr -12Cr -515.41Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/26/31 | $0.9766 | -6.10% | 80,74,274 |
| 30/26/30 | $1.040 | +4.00% | 99,21,218 |
| 29/26/29 | $1.000 | +10.62% | 2,85,46,582 |
| 28/26/28 | $0.9040 | -15.12% | 3,48,71,066 |
| 27/26/27 | $1.065 | -24.20% | 4,04,12,061 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- OTLK Stock
Select your edition
All financial news and data tailored to specific country editions

















